Experimental murine acremoniosis: An emerging opportunistic human infection

Medical Mycology

Volumn 52, Issue 1, 2014, Pages 29-35

  Fernández Silva, Fabiola ^a   Capilla, Javier ^b   Mayayo, Emilio ^a   Sutton, Deanna ^c   Guarro, Josep ^b  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

Acremonium; fungal infection; immunosuppressed mice; mycosis; virulence

Indexed keywords

BETA 1,3 GLUCAN; BETA GLUCAN; BETA-1,3-D-GLUCAN;

ACREMONIUM; ACREMONIUM KILIENSE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONIDIUM; CONTROLLED STUDY; DISEASE SEVERITY; EXPERIMENTAL INFECTION; EXPERIMENTAL MURINE ACREMONIOSIS; HISTOPATHOLOGY; HYALOHYPHOMYCOSIS; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; KIDNEY; LIVER; LUNG; MALE; MOUSE; MURINE MODEL; NONHUMAN; OPPORTUNISTIC INFECTION; SPECIES; SPLEEN; SURVIVAL; ANIMAL; ANIMAL STRUCTURES; BACTERIAL COUNT; BLOOD; COMMUNICABLE DISEASES, EMERGING; CYTOCHEMISTRY; DISEASE MODEL; HUMAN; MICROBIOLOGY; MICROSCOPY; MYCOSES; OPPORTUNISTIC INFECTIONS; PATHOGENICITY; PATHOLOGY; VIRULENCE;

ACREMONIUM; ANIMAL STRUCTURES; ANIMALS; BETA-GLUCANS; COLONY COUNT, MICROBIAL; COMMUNICABLE DISEASES, EMERGING; DISEASE MODELS, ANIMAL; HISTOCYTOCHEMISTRY; HUMANS; MALE; MICE; MICROSCOPY; MYCOSES; OPPORTUNISTIC INFECTIONS; SURVIVAL ANALYSIS; VIRULENCE;

EID: 84887503818     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693786.2013.797610     Document Type: Article

References (28)

1. Miceli MH, Lee SA. Emerging moulds: epidemiological trends and antifungal resistance. Mycoses 2011; 54: 666-678.
2. Das S, Saha R, Dar SA, Ramachandran VG. Acremonium species: a review of the etiological agents of emerging hyalo-hyphomycosis. Mycopathologia 2010; 170: 361-375.
3. Guarro J, Gams W, Pujol I, Gene J. Acremonium species: new emerging fungal opportunists-in vitro antifungal susceptibilities and review. Clin Infect Dis 1997; 25: 1222-1229.
4. Gams W. Cephalosporium-artige Schimmelpilze (Hy-phomycetes). Gustav Fischer Verlag, Stutgart, Germany. Mycologia 1973; 65: 253-257.
5. Simpson KW, Khan KN, Podell M, Johnson SE, Wilkie DA. Systemic mycosis caused by Acremonium sp. in a dog. J Am Vet Med Assoc 1993; 203: 1296-1299.
6. McCormack JG, McIntyre PB, Tilse MH, Ellis DH. Mycetoma associated with Acremonium falciforme infection. Med J Aust 1987; 147: 187-188.
7. Grunwald MH, Cagnano M, Mosovich M, Halevy S. Cutaneous infection due to Acremonium. J Eur Acad Dermatol Venereol 1998; 10: 58-61.
8. Schell WA, Perfect JR. Fatal, disseminated Acremonium strictum infection in a neutropenic host. J Clin Microbiol 1996; 34: 1333-1336.
9. Hitoto H, Pihet M, Weil B et al. Acremonium strictum fun-gaemia in a paediatric immunocompromised patient: diagnosis and treatment difficulties. Mycopathologia 2010; 170: 161-164.
10. Foell JL, Fischer M, Seibold M et al. Lethal double infection with Acremonium strictum and Aspergillus fumigatus during induction chemotherapy in a child with ALL. Pediatr Blood Cancer 2007; 49: 858-861.
11. Cornejo-Juarez P, Velasquez-Acosta C, Martinez-Roque V, Rangel-Cordero A, Volkow-Fernandez P. Asymptomatic fungemia caused by Acremonium sp associated with colonization of a central venous catheter. Gac Med Mex 2007; 143: 193-196.
12. Purnak T, Beyazit Y, Sahin GO, Shorbagi A, Akova M. A novel fungal pathogen under the spotlight Acremonium spp. associated fungaemia in an immunocompetent host. Mycoses 2011; 54: 78-80.
13. Khan Z, Al-Obaid K, Ahmad S et al. Acremonium kiliense: reappraisal of its clinical significance. J Clin Microbiol 2011; 49: 2342-2347.
14. Perdomo H, Sutton DA, Garcia D et al. Spectrum of clinically relevant Acremonium species in the United States. J Clin Micro-biol 2011; 49: 243-256.
15. Summerbell RC, Gueidan C, Schroers HJ et al. Acremonium phylogenetic overview and revision of Gliomastix, Sarocladium, and Trichothecium. Stud Mycol 2011; 68: 139-162.
16. Guarro J, Del Palacio A, Gené J, Cano J, González CG. A case of colonization of a prosthetic mitral valve by Acremonium stric-tum. Rev Iberoam Micol 2009; 26: 146-148.
17. Novicki TJ, LaFe K, Bui L et al. Genetic diversity among clinical isolates of Acremonium strictum determined during an investigation of a fatal mycosis. J Clin Microbiol 2003; 41: 2623-2628.
18. Graybill JR, Bocanegra R, Najvar LK, Loebenberg D, Luther MF. Granulocyte colony-stimulating factor and azole antifun-gal therapy in murine aspergillosis: role of immune suppression. Antimicrob Agents Chemother 1998; 42: 2467-2473.
19. Ortoneda M, Capilla J, Pastor FJ, Serena C, Guarro J. Interaction of granulocyte colony-stimulating factor and high doses of liposomal amphotericin B in the treatment of systemic murine scedosporiosis. Diagn Microbiol Infect Dis 2004; 50: 247-251.
20. Guarro J. Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi. J Antimicrob Chemother 2011; 66: 1447-1466.
21. Wetli CV, Weiss SD, Cleary TJ, Gyori E. Fungal cerebritis from intravenous drug abuse. J Forensic Sci 1984; 29: 260-268.
22. Walsh TJ, Groll A, Hiemenz J, Fleming et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10: 48-66.
23. Schell WA. New aspects of emerging fungal pathogens. A mul-tifaceted challenge. Clin Lab Med 1995; 15: 365-387.
24. Kedzierska A, Kochan P, Pietrzyk A, Kedzierska J. Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1 →3)-beta-D-glucan antigens. Eur J Clin Microbiol Infect Dis 2007; 26: 755-766.
25. Wiederhold NP, Najvar LK, Vallor AC et al. Assessment of serum (1-3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother 2008; 52: 1176-1178.
26. Lengerova M, Kocmanova I, Racil Z et al. Detection and measurement of fungal burden in a guinea pig model of invasive pulmonary aspergillosis by novel quantitative nested real-time PCR compared with galactomannan and (1, 3)-β-D-glucan detection. J Clin Microbiol 2012; 50: 602-608.
27. Yoshida M, Obayashi T, Iwama A et al. Detection of plasma (1 → 3)-beta-D-glucan in patients with Fusarium, Trichosporon, Saccharomyces and Acremonium fungaemias. J Med Vet Mycol 1997; 35: 371-374.
28. Capilla J, Clemons KV, Stevens DA. Animal models: an important tool in mycology. Med Mycol 2007; 45: 657-684.